FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, ...

The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s DXCM Stelo Glucose Biosensor System for over-the-counter use in children ages 2 and older who do not use insulin, expanding ...

The Stelo Glucose Biosensor System uses a wearable sensor, paired with an application installed on a compatible smartphone or ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom. The investment marks Oura’s Series D funding round and brings the company’s ...

Over-the-counter continuous glucose monitors have gained popularity over recent years. These devices are designed to help ...

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the companies' products to work together, with the goal being to help users see how nutrition and ...

A seasoned news and features author, Aakash operates at the intersection of tech, business, and marketing. Previously, he was an Editor at TechRadar and Mashable, before moving to Product Marketing ...

San Diego-based Dexcom, a maker of continuous glucose monitors, has filed for a patent for a system that would integrate a smartphone with a Dexcom device, detailing some of the features such a device ...

Nov 19 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion. Ōura, ...

Numerous comments on a Facebook group called “Dexcom G7 – Issues and Complaints” has brought to light a problem that users are referring to as “goose necking.” MD+DI learned more about this issue – ...

On the other hand, DexCom is a pure-play CGM company whose target market consists mainly of people with Type 1 and Type 2 ...